| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/0145445507309025 © 2008 SAGE Publications Cognitive-Behavioral Treatment for Panic Disorder With AgoraphobiaA Randomized, Controlled Trial and Cost-Effectiveness AnalysisUnivérsité of Montréal, Québéc
Univérsity of Québéc, Montréal
Univérsité Laval, Québéc City, Québéc
Sacré-Coeur Hospital of Montréal, Québéc A randomized, controlled trial was conducted to examine the cost-effectiveness of cognitive-behavioral treatment (CBT) for panic disorder with agoraphobia. A total of 100 participants were randomly assigned to standard (n = 33), group (n = 35), and brief (n = 32) treatment conditions. Results show significant clinical and statistical improvement on standard symptom measures and quality of life from baseline to posttreatment and 3-month follow-up, with no significant differences between treatment conditions. Compared with standard CBT, brief and group CBT incurred lower treatment costs and had a superior cost-effectiveness ratio, suggesting the potential of these alternative treatment conditions in increasing access to effective treatment.
Key Words: panic disorder agoraphobia cognitive-behavioral therapy cost-effectiveness brief treatment group treatment
|
